C84.14
Sézary disease, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Sézary disease is a rare and aggressive form of cutaneous T-cell lymphoma, a cancer that begins in the lymphocytes— a type of white blood cell involved in immune response. This disease primarily affects the skin but can also involve lymph nodes, particularly those in the axilla (armpit) and the upper limbs. When the lymph nodes in these regions are affected, it indicates a progression of the disease beyond the skin. Recognized under the ICD-10 code C84.14, Sézary disease requires careful medical evaluation and management to address its spread and symptoms.
Causes & Symptoms
Clinical Causes: Genetic mutations in T-cells that lead to uncontrolled growth Potential environmental exposures such as chemicals or radiation, though specific causes are not definitively known Immune system dysregulation that allows abnormal T-cell proliferation
Key Symptoms: Persistent skin redness, scaling, and itching, often widespread Presence of Sézary cells in the blood, detected through blood tests Swollen lymph nodes in the axilla and upper limbs Generalized skin thickening or erythroderma Persistent fatigue or malaise Possible secondary infections due to compromised skin barrier
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Sézary disease affecting specific lymph nodes involves a combination of clinical evaluation and laboratory tests. Doctors may start with a physical examination focusing on skin and lymph node swelling. Blood tests are essential to identify Sézary cells—abnormal lymphocytes characteristic of this disease. Skin biopsies help confirm the presence of malignant T-cells. Imaging studies, such as CT scans, are used to assess lymph node involvement. A comprehensive diagnosis integrates these findings to determine the extent of disease spread, particularly in the axillary and upper limb lymphatic regions.
Treatment Protocols: Management of Sézary disease may involve various approaches, often tailored to the disease stage and patient health. Common treatments include: - **Phototherapy and PUVA**: Light-based therapies to control skin symptoms. - **Systemic therapies**: Such as interferons, histone deacetylase inhibitors, or chemotherapeutic agents. - **Biological agents and monoclonal antibodies**: Targeting specific immune pathways involved in the disease. - **Radiation therapy**: Used locally or regionally to shrink swollen lymph nodes. - **Stem cell transplantation**: Considered in certain cases for long-term remission. Supportive care, including infection management and skin care, is also vital. Due to the complexity of the disease, treatment plans are typically developed by a multidisciplinary team specializing in lymphoma and blood cancers.
Clinical Advice & FAQs
Billing Guidance
Is C84.14 a billable ICD-10 code?
Yes, C84.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.14?
Clinical documentation must specify the nature of Sézary disease, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference